235 related articles for article (PubMed ID: 21724997)
1. Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica.
Luo D; Szaba FM; Kummer LW; Plow EF; Mackman N; Gailani D; Smiley ST
J Immunol; 2011 Aug; 187(4):1866-76. PubMed ID: 21724997
[TBL] [Abstract][Full Text] [Related]
2. In situ assays demonstrate that interferon-gamma suppresses infection-stimulated hepatic fibrin deposition by promoting fibrinolysis.
Mullarky IK; Szaba FM; Winchel CG; Parent MA; Kummer LW; Mackman N; Johnson LL; Smiley ST
J Thromb Haemost; 2006 Jul; 4(7):1580-7. PubMed ID: 16839357
[TBL] [Abstract][Full Text] [Related]
3. Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury.
Sullivan BP; Kassel KM; Jone A; Flick MJ; Luyendyk JP
Am J Pathol; 2012 Jun; 180(6):2321-9. PubMed ID: 22507835
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins.
Semeraro F; Ammollo CT; Semeraro N; Colucci M
Haematologica; 2009 Jun; 94(6):819-26. PubMed ID: 19377079
[TBL] [Abstract][Full Text] [Related]
5. Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model.
Shao Z; Nishimura T; Leung LL; Morser J
J Thromb Haemost; 2015 Jun; 13(6):1090-102. PubMed ID: 25851247
[TBL] [Abstract][Full Text] [Related]
6. Absence of thrombin-activatable fibrinolysis inhibitor protects against sepsis-induced liver injury in mice.
Renckens R; Roelofs JJ; ter Horst SA; van 't Veer C; Havik SR; Florquin S; Wagenaar GT; Meijers JC; van der Poll T
J Immunol; 2005 Nov; 175(10):6764-71. PubMed ID: 16272333
[TBL] [Abstract][Full Text] [Related]
7. Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis.
Boulaftali Y; Ho-Tin-Noe B; Pena A; Loyau S; Venisse L; François D; Richard B; Arocas V; Collet JP; Jandrot-Perrus M; Bouton MC
Circulation; 2011 Mar; 123(12):1326-34. PubMed ID: 21403095
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice.
Denorme F; Wyseure T; Peeters M; Vandeputte N; Gils A; Deckmyn H; Vanhoorelbeke K; Declerck PJ; De Meyer SF
Stroke; 2016 Sep; 47(9):2419-22. PubMed ID: 27470988
[TBL] [Abstract][Full Text] [Related]
9. Contribution of toll-like receptors 2 and 4 in an oral Yersinia enterocolitica mouse infection model.
Sing A; Tvardovskaia N; Rost D; Kirschning CJ; Wagner H; Heesemann J
Int J Med Microbiol; 2003 Nov; 293(5):341-8. PubMed ID: 14695062
[TBL] [Abstract][Full Text] [Related]
10. Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
Taketomi T; Szlam F; Bader SO; Sheppard CA; Levy JH; Tanaka KA
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):135-41. PubMed ID: 18277134
[TBL] [Abstract][Full Text] [Related]
11. Yersinia enterocolitica YopH-Deficient Strain Activates Neutrophil Recruitment to Peyer's Patches and Promotes Clearance of the Virulent Strain.
Dave MN; Silva JE; Eliçabe RJ; Jeréz MB; Filippa VP; Gorlino CV; Autenrieth S; Autenrieth IB; Di Genaro MS
Infect Immun; 2016 Nov; 84(11):3172-3181. PubMed ID: 27550935
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.
Binette TM; Taylor FB; Peer G; Bajzar L
Blood; 2007 Nov; 110(9):3168-75. PubMed ID: 17644733
[TBL] [Abstract][Full Text] [Related]
13. New insights into factors affecting clot stability: A role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R).
Bouma BN; Meijers JC
Semin Hematol; 2004 Jan; 41(1 Suppl 1):13-9. PubMed ID: 14872415
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic and coagulative activities of Yersinia pestis.
Korhonen TK; Haiko J; Laakkonen L; Järvinen HM; Westerlund-Wikström B
Front Cell Infect Microbiol; 2013; 3():35. PubMed ID: 23898467
[TBL] [Abstract][Full Text] [Related]
15. Host fibrinogen drives antimicrobial function in
Prasad JM; Negrón O; Du X; Mullins ES; Palumbo JS; Gilbertie JM; Höök M; Grover SP; Pawlinski R; Mackman N; Degen JL; Flick MJ
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443167
[TBL] [Abstract][Full Text] [Related]
16. Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).
Grosso G; Vikerfors A; Woodhams B; Adam M; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Svenungsson E; Antovic A
Thromb Res; 2017 Oct; 158():168-173. PubMed ID: 28669410
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-activatable fibrinolysis inhibitor is degraded by Salmonella enterica and Yersinia pestis.
Valls Serón M; Haiko J; DE Groot PG; Korhonen TK; Meijers JC
J Thromb Haemost; 2010 Oct; 8(10):2232-40. PubMed ID: 20704647
[TBL] [Abstract][Full Text] [Related]
18. Role of fibrinolysis in sepsis.
Gando S
Semin Thromb Hemost; 2013 Jun; 39(4):392-9. PubMed ID: 23446914
[TBL] [Abstract][Full Text] [Related]
19. Resistance of chemokine receptor 6-deficient mice to Yersinia enterocolitica infection: evidence of defective M-cell formation in vivo.
Westphal S; Lügering A; von Wedel J; von Eiff C; Maaser C; Spahn T; Heusipp G; Schmidt MA; Herbst H; Williams IR; Domschke W; Kucharzik T
Am J Pathol; 2008 Mar; 172(3):671-80. PubMed ID: 18258848
[TBL] [Abstract][Full Text] [Related]
20. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.
von dem Borne PA; Meijers JC; Bouma BN
Blood; 1995 Oct; 86(8):3035-42. PubMed ID: 7579397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
